← Back to Clinical Trials
Recruiting NCT07590050

NCT07590050 Catgut Embedding for Lumbar Spondylosis With Blood Stasis Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07590050
Status Recruiting
Phase
Sponsor University of Medicine and Pharmacy at Ho Chi Minh City
Condition Lumbar Spondylosis
Study Type INTERVENTIONAL
Enrollment 66 participants
Start Date 2026-03-11
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Catgut embedding using PDO threadElectro-acupunctureLifestyle and Exercise Counseling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 66 participants in total. It began in 2026-03-11 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if catgut embedding works to treat chronic low back pain in adults with lumbar spondylosis and "Blood Stasis" syndrome. The main questions it aims to answer are: Does catgut embedding lower back pain more effectively than electro-acupuncture? Does catgut embedding improve the daily physical activities of participants? Researchers will compare catgut embedding to electro-acupuncture to see which method works better to reduce pain and improve quality of life. All participants will also receive counseling on lifestyle changes and back exercises. Participants will: Be randomly assigned to receive either catgut embedding (2 sessions over 4 weeks) or electro-acupuncture (20 sessions over 4 weeks). Visit the clinic for treatments and checkups. Complete surveys about their pain levels and ability to perform daily tasks at the start, at 2 weeks, and at 4 weeks.

Eligibility Criteria

Inclusion Criteria: * Age and Gender: Patients aged 18 to 65 years, regardless of gender. * Diagnosis of Chronic Low Back Pain: Confirmed diagnosis of low back pain due to lumbar spondylosis with the following criteria: * Clinical: Mechanical spinal pain. * Radiographic (X-ray): Joint space narrowing, subchondral sclerosis, and osteophytes on the vertebral bodies. * Absence of systemic symptoms such as fever, unexplained weight loss, or anemia. * Duration: Pain duration exceeding 3 months. * Pain Intensity: Visual Analog Scale (VAS) score for low back pain \> 40 mm. * Traditional Medicine Diagnosis: Diagnosed with Low back pain under the "Blood Stasis" syndrome according to Decision No. 5013/QD-BYT (2020) by the Ministry of Health: Pain occurs after heavy lifting or sudden movement. Severe localized pain, pain increases with movement/pressure. Limited range of motion. Tongue: Purple or with stasis points. Pulse: Choppy. * Communication: Capable of communicating fluently in Vietnamese to complete survey questionnaires. * Consent: Volunteers who agree to participate and sign the Informed Consent Form. Exclusion Criteria: * Neurological Deficits: Patients with clinical neurological abnormalities in the lower limbs. * Surgical Indications: Patients with indications for spinal surgery due to severe neurological deficits. * Co-morbidities: Vertebral fractures, spinal inflammation/infection, malignant tumors, neuromuscular scoliosis, or degenerative neurological diseases. * Hypersensitivity: History of hypersensitivity or adverse reactions to electro-acupuncture or catgut embedding treatments.

Contact & Investigator

Central Contact

Thi Thuy Hang Le, MD, Spec. I

✉ ltthang.ckii.yhct24@ump.edu.vn

📞 +84-909789694

Frequently Asked Questions

Who can join the NCT07590050 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Lumbar Spondylosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07590050 currently recruiting?

Yes, NCT07590050 is actively recruiting participants. Contact the research team at ltthang.ckii.yhct24@ump.edu.vn for enrollment information.

Where is the NCT07590050 trial being conducted?

This trial is being conducted at Ho Chi Minh City, Vietnam.

Who is sponsoring the NCT07590050 clinical trial?

NCT07590050 is sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. The trial plans to enroll 66 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology